Hrt Financial LP Cassava Sciences Inc Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$21.59 - $27.88 $83,596 - $107,951	-3,872 Reduced 20.07%	15,417 $378,000
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $452,519 - $702,891	19,289 New	19,289 $465,000
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $165,828 - $370,466	9,630 New	9,630 $270,000

201

13.9M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.